Clearmind Medicine Stock Slides Friday: What's Happening?
Clearmind Medicine shares are trading lower Friday as investors weigh the biotech’s move to acquire a majority stake in an EV charging firm.
Stocks · News reference
Clearmind shares are trading lower. The company announced a definitive agreement to acquire a 51% controlling stake in Charging Robotics for an aggregate purchase price of $2.5 million.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Clearmind Medicine Announces $2.5M Deal To Acquire 51% Stake In EV Wireless Charging Firm Charging Robotics, Plus $1.5M Loan At 4%; Expects Close Week Of September 7
Clearmind Medicine Initiates Phase lla, Double-Blind, Placebo-Controlled Phase I/IIa Clinical Trial Evaluating CMND-100 For Treatment Of AUD
Clearmind Medicine Inc. (NASDAQ:CMND) (the "Company"), a clinical-stage biopharmaceutical company advancing non-hallucinogenic psychedelic-derived neuroplastogen for scalable treatment of neuropsychiatric,